Natural killer cells and malaria

Immunological Reviews

Volumn 214, Issue 1, 2006, Pages 251-263

  Roetynck, Sophie ^a,b,c   Baratin, Myriam ^a,b,c   Johansson, Sofia ^a,b,c   Lemmers, Céline ^a,b,c   Vivier, Eric ^a,b,c,d   Ugolini, Sophie ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Innate immunity; Microbe detection; Natural killer cells; Plasmodium

Indexed keywords

ANTIBODY; GAMMA INTERFERON; GANGLIOTETRAOSYLCERAMIDE; GANGLIOTETRAOSYLCERAMIDE ANTIBODY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; B LYMPHOCYTE; BRAIN MALARIA; CRYPTOSPORIDIUM PARVUM; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE PREDISPOSITION; ERYTHROCYTE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; MALARIA; MEROZOITE; MONOCYTE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PRIORITY JOURNAL; REVIEW; SCID MOUSE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TOXOPLASMA GONDII;

ANIMALS; HUMANS; KILLER CELLS, NATURAL; MALARIA; PLASMODIUM;

EID: 33750698937     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2006.00446.x     Document Type: Review

References (106)

1. Casanova JL, Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 2004;4:55-66.
2. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005;434:214-217.
3. Haldane JBS. The rate of mutation of human genes. Proc 8th Int Cong Genet 1949;(Hereditas Suppl. 35):267-273.
4. Allison AC. Protection afforded by sickle-cell trait against subtertian malareal infection. BMJ 1954;4857:290-294.
5. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005;77:171-192.
6. Frevert U, et al. Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol 2005;3:e192.
7. Amino R, et al. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat Med 2006;12:220-224.
8. Marsh K. Clinical features of Malaria. In: Wahlgren M, Perlmann P, eds. Malaria: Molecular and Clinical Aspects. Amsterdam: Harwood Academic Publishers, 1999: 87-117.
9. Beeson JG, Duffy PE. The immunology and pathogenesis of malaria during pregnancy. Curr Top Microbiol Immunol 2005;297:187-227.
10. Hunt NH, et al. Immunopathogenesis of cerebral malaria. Int J Parasitol 2006;36:569-582.
11. Ro DK, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006;440:940-943.
12. Achtman AH, Bull PC, Stephens R, Langhorne J. Longevity of the immune response and memory to blood-stage malaria infection. Curr Top Microbiol Immunol 2005;297:71-102.
13. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med 1999;5:340-343.
14. Alonso PL, et al. Duration of protection with RTS, S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 2005;366:2012-2018.
15. Korbel DS, Finney OC, Riley EM. Natural killer cells and innate immunity to protozoan pathogens. Int J Parasitol 2004;34:1517-1528.
16. Stevenson MM, Riley EM. Innate immunity to malaria. Nat Rev Immunol 2004;4:169-180.
17. Urban BC, Ing R, Stevenson MM. Early interactions between blood-stage Plasmodium parasites and the immune system. Curr Top Microbiol Immunol 2005;297:25-70.
18. Lanier LL, Phillips JH, Hackett J Jr, Tutt M, Kumar V. Natural killer cells: definition of a cell type rather than a function. J Immunol 1986;137:2735-2739.
19. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA. NK cell and DC interactions. Trends Immunol 2004;25:47-52.
20. Ferlazzo G, Munz C. NK cell compartments and their activation by dendritic cells. J Immunol 2004;172:1333-1339.
21. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2004;23:255-259.
22. Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 2004;5:996-1002.
23. Vivier E, Biron CA. A pathogen receptor on natural killer cells. Science 2002;296:1248-1249.
24. Vivier E, Nunes JA, Vely F. Natural killer cell signaling pathways. Science 2004;306:1517-1519.
25. Marti M, Good RT, Rug M, Knuepfer E, Cowman AF. Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science 2004;306:1930-1933.
26. Smith JD, Craig AG. The surface of the Plasmodium falciparum-infected erythrocyte. Curr Issues Mol Biol 2005;7:81-93.
27. Winter G, et al. SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes. J Exp Med 2005;201:1853-1863.
28. Coban C, et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 2005;201:19-25.
29. Yarovinsky F, et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005;308:1626-1629.
30. Krishnegowda G, et al. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 2005;280:8606-8616.
31. Hoebe K, et al. CD36 is a sensor of diacylglycerides. Nature 2005;433:523-527.
32. Pichyangkul S, et al. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J Immunol 2004;172:4926-4933.
33. Behr C, et al. Plasmodium falciparum stimuli for human gammadelta T cells are related to phosphorylated antigens of mycobacteria. Infect Immun 2004;64:2892-2896.
34. Farouk SE, Mincheva-Nilsson L, Krensky AM, Dieli F, Troye-Blomberg M. Gamma delta T cells inhibit in vitro growth of the asexual blood stages of Plasmodium falciparum by a granule exocytosis-dependent cytotoxic pathway that requires granulysin. Eur J Immunol 2004;34:2248-2256.
35. Bruce MC, Day KP. Cross-species regulation of Plasmodium parasitemia in semi-immune children from Papua New Guinea. Trends Parasitol 2003;19:271-277.
36. Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005;5:722-735.
37. Nussenzweig RS, Vanderberg J, Most H, Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967;216:160-162.
38. Scharton-Kersten TM, Sher A. Role of natural killer cells in innate resistance to protozoan infections. Curr Opin Immunol 1997;9:44-51.
39. Langhorne J, Quin SJ, Sanni LA. Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology. Chem Immunol 2002;80:204-228.
40. Good MF. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies. Trends Immunol 2005;26:295-297.
41. Vanderberg JP, Nussenzweig RS, Most H, Orton CG. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. II. Effects of radiation on sporozoites. J Parasitol 1968;54:1175-1180.
42. Sigler CI, Leland P, Hollingdale MR. In vitro infectivity of irradiated Plasmodium berghei sporozoites to cultured hepatoma cells. Am J Trop Med Hyg 1984;33:544-547.
43. Krzych U, Schwenk J. The dissection of CD8 T cells during liver-stage infection. Curr Top Microbiol Immunol 2005;297:1-24.
44. Doolan DL, Martinez-Alier N. Immune response to pre-erythrocytic stages of malaria parasites. Curr Mol Med 2006;6:169-185.
45. Doolan DL, Hoffman SL. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. J Immunol 1999;163:884-892.
46. De Souza JB, Williamson KH, Otani T, Playfair JH. Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun 1997;65:1593-1598.
47. Choudhury HR, Sheikh NA, Bancroft GJ, Katz DR, De Souza JB. Early nonspecific immune responses and immunity to blood-stage nonlethal Plasmodium yoelii malaria. Infect Immun 2000;68:6127-6132.
48. Roland J, et al. NK cell response to Plasmodium infection and control of intrahepatic parasite development. J Immunol 2006;177:1223-1239.
49. Lee SH, et al. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J Exp Med 2003;197:515-526.
50. Smith HR, et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 2002;99:8826-8831.
51. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002;296:1323-1326.
52. Lee SH, et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 2001;28:42-45.
53. Brown MG, et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001;292:934-937.
54. Sjolin H, et al. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J Exp Med 2002;195:825-834.
55. French AR, et al. Escape of mutant double-stranded DNA virus from innate immune control. Immunity 2004;20:747-756.
56. Eugui EM, Allison AC. Differences in susceptibility of various mouse strains to haemoprotozoan infections: possible correlation with natural killer activity. Parasite Immunol 1980;2:277-292.
57. Mohan K, Moulin P, Stevenson MM. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. J Immunol 1997;159:4990-4998.
58. Skamene E, Stevenson MM, Lemieux S. Murine malaria: dissociation of natural killer (NK) cell activity and resistance to Plasmodium chabaudi. Parasite Immunol 1983;5:557-565.
59. Kitaguchi T, Nagoya M, Amano T, Suzuki M, Minami M. Analysis of roles of natural killer cells in defense against Plasmodium chabaudi in mice. Parasitol Res 1996;82:352-357.
60. Ojo-Amaize EA, Vilcek J, Cochrane AH, Nussenzweig RS. Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon, and activate natural killer cells. J Immunol 1984;133:1005-1009.
61. Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 2003;24:491-499.
62. Yokoyama WM, Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003;3:304-316.
63. Hansen DS, Siomos MA, Buckingham L, Scalzo AA, Schofield L. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity 2003;18:391-402.
64. Hansen DS, et al. The natural killer complex regulates severe malarial pathogenesis and influences acquired immune responses to Plasmodium berghei ANKA. Infect Immun 2005;73:2288-2297.
65. Favre N, Ryffel B, Bordmann G, Rudin W. The course of Plasmodium chabaudi chabaudi infections in interferon-gamma receptor deficient mice. Parasite Immunol 1997;19:375-383.
66. Stevenson MM, Tam MF, Wolf SF, Sher A. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J Immunol 1995;155:2545-2556.
67. Jacobs P, Radzioch D, Stevenson MM. A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect Immun 1996;64:535-541.
68. Luty AJ, et al. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis 1999;179:980-988.
69. Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, Riley EM. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis 2002;185:971-979.
70. Kojima S, Nagamine Y, Hayano M, Looareesuwan S, Nakanishi K. A potential role of interleukin 18 in severe falciparum malaria. Acta Trop 2004;89:279-284.
71. Perkmann T, Winkler H, Graninger W, Kremsner PG, Winkler S. Circulating levels of the interleukin (IL)-4 receptor and of IL-18 in patients with Plasmodium falciparum malaria. Cytokine 2005;29:153-158.
72. Nagamine Y, et al. Involvement of interleukin-18 in severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 2003;97:236-241.
73. Hermsen CC, et al. Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections. Clin Exp Immunol 2003;132:467-472.
74. Scragg IG, Hensmann M, Bate CA, Kwiatkowski D. Early cytokine induction by Plasmodium falciparum is not a classical endotoxin-like process. Eur J Immunol 1999;29:2636-2644.
75. Ojo-Amaize EA, et al. Positive correlation between degree of parasitemia, interferon titers, and natural killer cell activity in Plasmodium falciparum-infected children. J Immunol 1981;127:2296-2300.
76. Artavanis-Tsakonas K, Riley EM. Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes. J Immunol 2002;169:2956-2963.
77. Artavanis-Tsakonas K, et al. Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. J Immunol 2003;171:5396-5405.
78. Baratin M, et al. Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc Natl Acad Sci U S A 2005;102:14747-14752.
79. Korbel DS, Newman KC, Almeida CR, Davis DM, Riley EM. Heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes. J Immunol 2005;175:7466-7473.
80. Pouvelle B, Fusai T, Lepolard C, Gysin J. Biological and biochemical characteristics of cytoadhesion of Plasmodium falciparum-infected erythrocytes to chondroitin-4-sulfate. Infect Immun 1998;66:4950-4956.
81. Pouvelle B, Buffet PA, Lepolard C, Scherf A, Gysin J. Cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes. Nat Med 2000;6:1264-1268.
82. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature 2002;415:673-679.
83. Chakravorty SJ, Craig A. The role of ICAM-1 in Plasmodium falciparum cytoadherence. Eur J Cell Biol 2005;84:15-27.
84. Gamain B, Trimnell AR, Scheidig C, Scherf A, Miller LH, Smith JD. Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. J Infect Dis 2005;191:1010-1013.
85. Viebig NK, et al. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep 2005;6:775-781.
86. Orago AS, Facer CA. Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: stimulation by cytokines and inhibition by neomycin. Clin Exp Immunol 1991;86:22-29.
87. Mavoungou E, Luty AJ, Kremsner PG. Natural killer (NK) cell-mediated cytolysis of Plasmodium falciparum-infected human red blood cells in vitro. Eur Cytokine Netw 2003;14:134-142.
88. Rubio V, et al. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 2003;9:1377-1382.
89. Wolint P, Betts MR, Koup RA, Oxenius A. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J Exp Med 2004;199:925-936.
90. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004;294:15-22.
91. Bryceson YT, March ME, Barber DF, Ljunggren HG, Long EO. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 2005;202:1001-1012.
92. Anfossi N, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006;25:331-342.
93. Deloron P, Chougnet C, Lepers JP, Tallet S, Coulanges P. Protective value of elevated levels of gamma interferon in serum against exoerythrocytic stages of Plasmodium falciparum. J Clin Microbiol 1991;29:1757-1760.
94. Hill AV. Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat Rev Immunol 2006;6:21-32.
95. Gysin J, Pouvelle B, Fievet N, Scherf A, Lepolard C. Ex vivo desequestration of Plasmodium falciparum-infected erythrocytes from human placenta by chondroitin sulfate A. Infect Immun 1999;67:6596-6602.
96. Lekana Douki JB, et al. Sequestration of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A, a receptor for maternal malaria: monoclonal antibodies against the native parasite ligand reveal panreactive epitopes in placental isolates. Blood 2002;100:1478-1483.
97. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002;2:656-663.
98. Macchiarini F, Manz MG, Palucka AK, Shultz LD. Humanized mice: are we there yet? J Exp Med 2005;202:1307-1311.
99. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 2000;356:1795-1799.
100. Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol 2006;298:225-257.
101. Martin-Fontecha A, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004;5:1260-1265.
102. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural killer cells and dendritic cells: "l'union fait la force". Blood 2005;106:2252-2258.
103. Laouar Y, Sutterwala FS, Gorelik L, Flavell RA. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol 2005;6:600-607.
104. Smith JD, Gamain B, Baruch DI, Kyes S. Decoding the language of var genes and Plasmodium falciparum sequestration. Trends Parasitol 2001;17:538-545.
105. Hernandez-Valladares M, Naessens J, Iraqi FA. Genetic resistance to malaria in mouse models. Trends Parasitol 2005;21:352-355.
106. Lamb TJ, Brown DE, Potocnik AJ, Langhorne J. Insights into the immunopathogenesis of malaria using mouse models. Expert Rev Mol Med 2006;8:1-22.